FDA 483 - MSD International GmbH - March 28, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 report details three observations at MSD International GmbH T/A MSD Ireland (Biotech Dublin), a drug substance manufacturer in Swords, Ireland. The inspection revealed deficiencies in written procedures for deviation management, inadequate validation and control of QC microbiology testing, and insufficient sampling and testing for component identity and microbial contamination of drug substance bags. These issues indicate significant concerns regarding the firm's quality control and manufacturing processes.
ID · 0d76bcd2-fe49-4540-a853-7347db067022